Healius Limited announced the divestment of its Montserrat Day Hospitals

Dec 09, 2022

Healius Limited (ASX: HLS) announced that it had signed a binding agreement with Nexus Hospitals to divest its Montserrat Day Hospitals, an operator of 11 specialist short-stay hospitals and hematology/oncology clinics, for an enterprise value of up to AU$138.6 million including deferred contingent consideration of up to AU$11.4 million. Completion of the transaction is anticipated to take place in the first half of the calendar year 2023.

It remains subject to a limited number of conditions precedent customary for a transaction of this nature. The company will continue to offer pathology services across several existing Montserrat facilities with an option to expand the provision of diagnostic services with Nexus Hospitals.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com